日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting SPAK suppresses progression and averts an immune exhaustive microenvironment in hepatocellular carcinoma

靶向SPAK可抑制肝细胞癌的进展并避免免疫耗竭的微环境。

Pan, Yonglong; Zeng, Chenglong; He, Yi; Chang, Ruizhi; Wu, Jingjing; Yuan, Chaoyi; Li, Haisen; Su, Chen; Han, Mengzhen; Li, Pengcheng; Li, Xinxin; Zhang, Hongwei; Liu, Furong; Liang, Huifang; Li, Zifu; Wu, Mi; Xia, Limin; Liu, Jianfeng; Chen, Xiaoping; Zhang, Wanguang; Zhang, Bixiang; Ding, Ze-Yang

Tumor-Induced Rewiring of Splenic Niches: from Immune Organ to Cancer Accomplice

肿瘤诱导的脾脏微环境重塑:从免疫器官到癌症帮凶

Yuan, Tong; Liu, Junjie; Zhang, Chunyu; Lv, Xing; Tan, Guan; Xue, Lin; Zhang, Erlei; Liang, Huifang; Huang, Zhiyong

ITLN1, orchestrated by the IFNγ-IRF1 axis, suppresses hepatocellular carcinoma proliferation via ERK1/2 activation

ITLN1 在 IFNγ-IRF1 轴的调控下,通过激活 ERK1/2 抑制肝细胞癌的增殖。

Yuan, Tong; Liu, Junjie; Zhu, Ronghua; Li, Jiang; Huang, Zhiyong; Liang, Huifang; Tao, Haisu; Zhang, Erlei

SPP1+ Macrophages and the Orchestration of Spatially Organized Immunosuppression in Cancer

SPP1+巨噬细胞与癌症中空间组织免疫抑制的调控

Li, Fanshu; Xu, Dafeng; Tang, Zhen; Lai, Yangfeng; Liu, Qiumeng; Liang, Huifang; Dong, Hanhua; Song, Jia

Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma.

辛伐他汀可克服 AKT 过度激活的肝内胆管癌中 pPCK1-pLDHA-SPRINGlac 轴介导的铁死亡和化疗免疫疗法耐药性

Zhu Jinghan, Xiong Yixiao, Zhang Yuxin, Liang Huifang, Cheng Kun, Lu Yuanxiang, Cai Guangzhen, Wu Yang, Fan Yunhui, Chen Xiaoping, Zhu Hong, Ding Zeyang, Zhang Wanguang

MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation

MET通过促进TRIB3介导的FOXO1降解来促进肝细胞癌的发生发展。

Wang, Tiantian; Rao, Dean; Fu, Chenan; Sun, Zhoubin; Luo, Yiming; Lu, Junli; Jin, Jie; Li, Han; Fan, Feimu; Liang, Huifang; Huang, Wenjie; Xia, Limin

Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma

短期饥饿可通过重塑肝细胞癌中的肿瘤相关巨噬细胞来增强抗PD-L1疗法的疗效

Cheng, Kun; Cai, Ning; Yang, Xing; Li, Danfeng; Zhu, Jinghan; Yang, Hui Yuan; Liu, Sha; Ning, Deng; Liang, Huifang; Zhao, Jianping; Zhang, Zhanguo; Zhang, Wanguang

Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKT

破坏细胞核内CCDC137介导的LZTS2和β-TrCP相互作用可通过β-catenin和AKT抑制肝细胞癌的发生发展。

Xu, Lei; Liu, Qiumeng; Liu, Hailing; Fan, Feimu; Li, Pengcheng; Yue, Shiwei; Mo, Jie; Liu, Zhicheng; Dong, Renshun; Zhang, Xuewu; Dong, Hanhua; Liang, Huifang; Chen, Xiaoping; Zhang, Bixiang; Chen, Lin; Chen, Jin

CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression.

CKAP4 在肝细胞癌中的作用:竞争性 RETREG1/FAM134B 结合、网状吞噬调控和癌症进展

Mo Jie, Su Chen, Li Pengcheng, Yang Zhenhua, Tao Ran, Liu Qiumeng, Yuan Chaoyi, Xu Lei, Ge Qianyun, Ning Deng, Liang Huifang, Zhu Haidan, Luo Yan, Chen Xiaoping, Chen Jin, Zhang Bixiang

PARK7-driven IGF2BP3-K76 lactylation mediates ferroptosis and HAIC resistance in hepatocellular carcinoma

PARK7驱动的IGF2BP3-K76乳酸化介导肝细胞癌中的铁死亡和HAIC抵抗

Zhu, Zhiwen; Xia, Xinyu; Lu, Yuanxiang; Li, Danfeng; He, Xincheng; Zhang, Baohua; Xiong, Ge; Zhang, Wanguang; Liang, Huifang; Zhu, Hong